Satio and Nanowear today announced that they partnered to advance patient-friendly, home-based diagnostic and therapeutic care. The collaboration aims to integrate Nanowear’s at-home AI-based nanotechnology biomarker diagnostic platform with Satio’s at-home blood draw diagnostics and drug delivery systems/patches. This would combine time-synchronous, in vivo and in vitro diagnostics for precision therapeutics and individualized AI-based risk […]
Satio
Satio completes development, testing of remotely controllable, at-home intradermal drug delivery system
Satio announced today that it completed a Small Business Innovation Research (SBIR) contract for its intradermal drug delivery system. The NIH’s Advanced Research Projects Agency for Health (ARPA-H) awarded Satio the $3.5 million in September 2023. This contract aimed to help the company develop SatioRx, its intradermal drug delivery device. The compact, inexpensive device features […]
Satio wins $3.5M contract to develop at-home transdermal drug delivery device
Satio announced that a National Institutes for Health agency awarded it a $3.5 million Small Business Innovation Research (SBIR) contract. Awarded by the NIH’s Advanced Research Projects Agency for Health (ARPA-H), the contract helps the company develop SatioRx. This drug delivery device, compact and inexpensive, features disposable microneedle components for precise delivery. It remotely enables […]
